News

November 20, 2024

Results from Cardiosense’s SEISMIC-HF I Study of a Machine Learning Model to Non-Invasively Assess Cardiac Filling Pressure Presented as Late-Breaking Science at American Heart Association’s 2024 Scientific Sessions

October 29, 2024

Cardiosense Presents Interim Clinical Study Data for Machine Learning Algorithm to Aid in Heart Failure Management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium

May 14, 2024

Cardiosense CardioTag Named “Best IoT Healthcare Wearable Device” in 8th Annual MedTech Breakthrough Awards Program

October 3, 2023

Cardiosense Begins Enrollment in Nationwide Heart Failure Study

December 14, 2022

Cardiosense lands $15M for AI to predict worsening heart disease from wearables

December 8, 2022

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance AI Platform for Heart Disease

April 13, 2022

Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?

February 15, 2022

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

December 8, 2020

TMCx has progressed virtually in 2020 including Bootcamp, an intensive diligence and relationship building period designed to initiate…

Investigational Device. Limited by Federal (or United States) Law to Investigational Use

© Copyright 2022 by Cardiosense. All Rights Reserved

400 N Aberdeen St Suite 900
Chicago, IL 60642

[email protected]

© Copyright 2022 by Cardiosense. All Rights Reserved